Literature DB >> 11245825

Novel synthetic analogue of ACTH 4-10 (Semax) but not glycine prevents the enhanced nitric oxide generation in cerebral cortex of rats with incomplete global ischemia.

V G Bashkatova1, V B Koshelev, O E Fadyukova, A A Alexeev, A F Vanin, K S Rayevsky, I P Ashmarin, D M Armstrong.   

Abstract

This work investigates whether nitric oxide production and lipid peroxidation contribute to the pathophysiology of ischemia and whether glycine and a novel Russian compound, Semax are neuroprotective via a mechanism involving the regulation nitric oxide (NO) and lipid peroxidation. In brief, nitric oxide and indices of lipid peroxidation were elevated following global ischemia. While glycine proved ineffective in reducing NO levels or ameliorating the neurological deficits following global ischemia, Semax proved to be highly effective in abating the rise in nitric oxide and restoring neurologic functioning.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11245825     DOI: 10.1016/s0006-8993(00)03324-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Semax increases erythrocyte deformability in the shearing blood stream in intact rats and rats with cerebral ischemia.

Authors:  O E Fadyukova; A Yu Tyurina; A E Lugovtsov; A V Priezzhev; L A Andreeva; V B Koshelev; N F Myasoedov
Journal:  Dokl Biol Sci       Date:  2011-09-28

2.  The effect of Semax and its C-end peptide PGP on the morphology and proliferative activity of rat brain cells during experimental ischemia: a pilot study.

Authors:  Vasily V Stavchansky; Vadim V Yuzhakov; Alexandra Yu Botsina; Veronika I Skvortsova; Lyubov N Bondurko; Marina G Tsyganova; Svetlana A Limborska; Nikolay F Myasoedov; Lyudmila V Dergunova
Journal:  J Mol Neurosci       Date:  2010-07-09       Impact factor: 3.444

3.  Semax, an analog of ACTH(4-7), regulates expression of immune response genes during ischemic brain injury in rats.

Authors:  Ekaterina V Medvedeva; Veronika G Dmitrieva; Svetlana A Limborska; Nikolay F Myasoedov; Lyudmila V Dergunova
Journal:  Mol Genet Genomics       Date:  2017-03-02       Impact factor: 3.291

4.  Strategy to discover full-length amyloid-beta peptide ligands using high-efficiency microarray technology.

Authors:  Clelia Galati; Natalia Spinella; Lucio Renna; Danilo Milardi; Francesco Attanasio; Michele Francesco Maria Sciacca; Corrado Bongiorno
Journal:  Beilstein J Nanotechnol       Date:  2017-11-20       Impact factor: 3.649

5.  Novel Insights into the Protective Properties of ACTH(4-7)PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia-Reperfusion in Rats.

Authors:  Ivan B Filippenkov; Vasily V Stavchansky; Alina E Denisova; Vadim V Yuzhakov; Larisa E Sevan'kaeva; Olga Y Sudarkina; Veronika G Dmitrieva; Leonid V Gubsky; Nikolai F Myasoedov; Svetlana A Limborska; Lyudmila V Dergunova
Journal:  Genes (Basel)       Date:  2020-06-22       Impact factor: 4.096

6.  Semax, a Synthetic Regulatory Peptide, Affects Copper-Induced Abeta Aggregation and Amyloid Formation in Artificial Membrane Models.

Authors:  Michele F M Sciacca; Irina Naletova; Maria Laura Giuffrida; Francesco Attanasio
Journal:  ACS Chem Neurosci       Date:  2022-01-26       Impact factor: 4.418

7.  The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis.

Authors:  Ekaterina V Medvedeva; Veronika G Dmitrieva; Oksana V Povarova; Svetlana A Limborska; Veronika I Skvortsova; Nikolay F Myasoedov; Lyudmila V Dergunova
Journal:  BMC Genomics       Date:  2014-03-24       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.